Search Results

The Right Angle Laser Fibers and Optilase Lasers are indicated for a wide variety of surgical uses including incision, excision, resection, vaporization, ablation, coagulation and hemostasis. In addition, they are indicated for coagulation of soft tissue for prostatectomy in the treatment of benign prostatic hyperplasia (BPH).

The Optilase laser systems are continuous wave Nd: YAG energy sources equipped with an aiming beam, adjustable power output, and a fiber optic connector.

The Right Anale Laser Fibers are fiber optic Nd:YAG energy delivery systems consisting of : a three meter length of buffered quartz fiber, a tip which allows delivery of laser energy, and a fiber optic connector.

The provided text does not contain information about acceptance criteria and a study proving a device meets those criteria in the way a medical device submission for AI/ML would. The document describes a 510(k) submission for laser fibers and laser systems for BPH treatment from 1997.

Therefore, I cannot fulfill your request with the given input. The categories you listed (e.g., acceptance criteria table, sample size for test set, number of experts for ground truth, MRMC study, standalone performance, training set details) are typical for AI/ML device evaluations, which are not detailed in this historical 510(k) summary.

The document states:

• No nonclinical tests were submitted.
• A limited clinical study was undertaken to provide information related to Visual Laser Ablation of the Prostate (VLAP) with 60 watts of laser power. These data were compared to data obtained from an earlier study in which VLAP at 40 watts of laser power was compared to TURP.
• Conclusions: "The results of the comparative data submitted... demonstrate that VLAP, whether it be performed at 40 watt treatment parameters, is a viable alternative to TURP."

This indicates a clinical comparison study, but it does not specify acceptance criteria, test set details, ground truth methods, or other elements pertinent to AI/ML device validation.

Ask a specific question about this device

The Right Angle Laser Fiber and Optilase Lasers are indicated for a wide variety of I no Right , trying incision, excision, resection, vaporization, ablation, coagulation, Surglour asso moraumy of benign prostatic hyperplasia (BPH) and other urological conditions.

The Right Angle Laser Fiber is a fiber optic Nd:YAG energy delivery system consisting of: r ne right kingth of buffered quartz fiber, a tip which allows delivery of laser energy, and a fiber optic connector.

The Optilase laser systems are continuous-wave Nd:YAG energy sources equipped with an aiming beam, adjustable power output, and a fiber optic connector.

The provided text describes a medical device submission (510(k)) for Right Angle Laser Fibers and Optilase Nd:YAG Laser Systems. The information focuses on the device description, intended use, and a clinical study comparing Visual Laser Ablation of the Prostate (VLAP) using the device to Transurethral Resection of the Prostate (TURP) for Benign Prostatic Hyperplasia (BPH).

However, the document does not provide the specific acceptance criteria or detailed results of the study that would allow for a table comparing acceptance criteria to reported device performance. It simply states that the clinical data show the devices are "safe and effective."

Therefore, I cannot populate the table or provide detailed answers to many of the questions as the specific information is not present in the provided text.

Here's a breakdown of what can be extracted and what is missing:

1. Table of Acceptance Criteria and Reported Device Performance:

2. Sample size used for the test set and the data provenance:

• Sample Size: Not specified in the document. The study is described as "prospective, controlled and well-matched," but the number of participants is not mentioned.
• Data Provenance: The country of origin is not explicitly stated for the clinical study. It is a "prospective, controlled and well-matched study."

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

• This information is not provided in the document. The study compares VLAP to TURP, implying a direct clinical outcome comparison rather than an expert-driven ground truth for a discrete test set.

4. Adjudication method for the test set:

• This information is not provided in the document.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

• An MRMC study was not done. This study is a clinical comparison of two surgical procedures (VLAP vs. TURP), not an AI-assisted diagnostic or interpretative system being evaluated by human readers. The devices described are surgical lasers and fibers, not AI algorithms for interpretation.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

• This is not applicable as the devices are surgical instruments, not standalone AI algorithms.

7. The type of ground truth used:

• The "ground truth" implicitly used is clinical outcomes for Benign Prostatic Hyperplasia (BPH) treatment, comparing the effectiveness of VLAP (using the device) to TURP. Specific outcome measures (e.g., symptom scores, flow rates, re-operation rates) are not detailed in this summary.

8. The sample size for the training set:

• Not applicable. The clinical study described is a comparison of surgical procedures. There is no mention of a "training set" in the context of an AI algorithm.

9. How the ground truth for the training set was established:

• Not applicable for the same reasons as point 8.

Ask a specific question about this device